Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Biohaven Pharmaceutical Holding EPS - Earnings per Share 2016-2021 | BHVN

Biohaven Pharmaceutical Holding annual and quarterly earnings per share history from 2016 to 2021. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Biohaven Pharmaceutical Holding EPS for the quarter ending March 31, 2021 was $-4.27, a 39.09% increase year-over-year.
  • Biohaven Pharmaceutical Holding EPS for the twelve months ending March 31, 2021 was $-14.26, a 13.44% increase year-over-year.
  • Biohaven Pharmaceutical Holding 2020 annual EPS was $-13.06, a 19.71% increase from 2019.
  • Biohaven Pharmaceutical Holding 2019 annual EPS was $-10.91, a 77.4% increase from 2018.
  • Biohaven Pharmaceutical Holding 2018 annual EPS was $-6.15, a 23% increase from 2017.
  
Biohaven Pharmaceutical Holding Annual EPS
2020 $-13.06
2019 $-10.91
2018 $-6.15
2017 $-5.00
2016 $-5.05
2015 $-0.91
Biohaven Pharmaceutical Holding Quarterly EPS
2021-03-31 $-4.27
2020-12-31 $-3.64
2020-09-30 $-3.27
2020-06-30 $-3.08
2020-03-31 $-3.07
2019-12-31 $-2.79
2019-09-30 $-2.04
2019-06-30 $-4.67
2019-03-31 $-1.41
2018-12-31 $-1.29
2018-09-30 $-1.53
2018-06-30 $-1.01
2018-03-31 $-2.32
2017-12-31 $-0.29
2017-09-30 $-1.19
2017-06-30 $-1.78
2017-03-31 $-1.74
2016-12-31 $-2.09
2016-09-30 $-2.16
2016-06-30 $-0.55
2016-03-31 $-0.25
2015-12-31 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.233B $0.064B
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $152.593B 10.58
Amgen (AMGN) United States $142.329B 15.36
Moderna (MRNA) United States $140.065B 279.06
CSL (CSLLY) Australia $98.894B 0.00
Gilead Sciences (GILD) United States $86.563B 9.22
Illumina (ILMN) United States $72.344B 104.32
BioNTech SE (BNTX) Germany $68.099B 49.38
Regeneron Pharmaceuticals (REGN) United States $62.472B 17.89
Vertex Pharmaceuticals (VRTX) United States $51.903B 21.38
Biogen (BIIB) United States $48.495B 13.31
Genmab (GMAB) Denmark $29.452B 34.50
BeiGene (BGNE) Cayman Islands $29.278B 0.00
Genmab (GNMSF) Denmark $27.925B 6.42
Seagen (SGEN) United States $26.423B 45.64
Horizon Therapeutics Public (HZNP) Ireland $22.713B 29.04
Alnylam Pharmaceuticals (ALNY) United States $21.441B 0.00
Exact Sciences (EXAS) United States $20.234B 0.00
Bio-Rad Laboratories (BIO.B) United States $20.098B 48.83
Bio-Techne Corp (TECH) United States $18.450B 97.01
Incyte (INCY) United States $17.440B 34.48
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.427B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.217B 0.00
Novavax (NVAX) United States $15.059B 0.00
Zai Lab (ZLAB) China $14.236B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.078B 128.40
Guardant Health (GH) United States $12.037B 0.00
QIAGEN (QGEN) Netherlands $11.853B 21.05
Repligen (RGEN) United States $11.526B 103.92
CureVac (CVAC) Germany $10.125B 0.00
Intellia Therapeutics (NTLA) United States $9.385B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.264B 0.00
Fate Therapeutics (FATE) United States $8.105B 0.00
Mirati Therapeutics (MRTX) United States $8.083B 0.00
Denali Therapeutics (DNLI) United States $7.744B 277.83
Acceleron Pharma (XLRN) United States $7.454B 0.00
Legend Biotech (LEGN) United States $6.911B 0.00
Ascendis Pharma (ASND) Denmark $6.226B 0.00
Halozyme Therapeutics (HALO) United States $6.107B 33.51
SWEDISH ORP BIO (BIOVF) Sweden $6.000B 21.50
Beam Therapeutics (BEAM) United States $5.780B 0.00
Twist Bioscience (TWST) United States $5.737B 0.00
I-Mab (IMAB) China $5.633B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.582B 0.00
Apellis Pharmaceuticals (APLS) United States $5.483B 0.00
Adaptive Biotechnologies (ADPT) United States $5.434B 0.00
NeoGenomics (NEO) United States $5.390B 914.20
Sarepta Therapeutics (SRPT) United States $5.328B 0.00
Exelixis (EXEL) United States $5.243B 83.65
Blueprint Medicines (BPMC) United States $4.933B 15.02
Vir Biotechnology (VIR) United States $4.797B 0.00
Reata Pharmaceuticals (RETA) United States $4.698B 0.00
Arvinas (ARVN) United States $4.677B 0.00
AbCellera Biologics (ABCL) $4.278B 0.00
SpringWorks Therapeutics (SWTX) United States $4.072B 0.00
Certara (CERT) United States $4.046B 0.00
Arena Pharmaceuticals (ARNA) United States $3.963B 0.00
Alkermes (ALKS) Ireland $3.928B 0.00
Galapagos (GLPG) Belgium $3.925B 0.00
Emergent Biosolutions (EBS) United States $3.450B 6.87
ACADIA Pharmaceuticals (ACAD) United States $3.437B 0.00
Berkeley Lights (BLI) United States $3.207B 0.00
Intra-Cellular Therapies (ITCI) United States $2.934B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.885B 0.00
Editas Medicine (EDIT) United States $2.770B 0.00
Heska (HSKA) United States $2.629B 1146.23
Kymera Therapeutics (KYMR) United States $2.619B 0.00
Alector (ALEC) United States $2.614B 0.00
Insmed (INSM) United States $2.509B 0.00
Instil Bio (TIL) United States $2.500B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.489B 0.00
Sorrento Therapeutics (SRNE) United States $2.476B 0.00
Vericel (VCEL) United States $2.468B 665.50
Myriad Genetics (MYGN) United States $2.452B 0.00
ALX Oncology Holdings (ALXO) United States $2.413B 0.00
Amicus Therapeutics (FOLD) United States $2.347B 0.00
Arcus Biosciences (RCUS) United States $2.332B 0.00
Prothena (PRTA) Ireland $2.295B 0.00
Morphic Holding (MORF) United States $2.183B 0.00
Revance Therapeutics (RVNC) United States $2.145B 0.00
MorphoSys AG (MOR) Germany $2.129B 0.00
Cytokinetics (CYTK) United States $2.083B 0.00
Atea Pharmaceuticals (AVIR) United States $2.078B 0.00
Protagonist Therapeutics (PTGX) United States $2.066B 0.00
Seer (SEER) $2.032B 0.00
Ligand Pharmaceuticals (LGND) United States $2.032B 33.98
Celldex Therapeutics (CLDX) United States $1.979B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.929B 0.00
Myovant Sciences (MYOV) United Kingdom $1.910B 0.00
Global Blood Therapeutics (GBT) United States $1.786B 0.00
C4 Therapeutics (CCCC) United States $1.766B 0.00
Bluebird Bio (BLUE) United States $1.752B 0.00
Castle Biosciences (CSTL) United States $1.724B 0.00
Inovio Pharmaceuticals (INO) United States $1.717B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.675B 0.00
Bionano Genomics (BNGO) United States $1.665B 0.00
Genetron Holdings (GTH) China $1.648B 0.00
Zymeworks (ZYME) Canada $1.636B 0.00
NGM Biopharmaceuticals (NGM) United States $1.634B 0.00
PHARMA MAR SA (PHMMF) Spain $1.628B 0.00
Amarin (AMRN) Ireland $1.587B 0.00
Avid Bioservices (CDMO) United States $1.585B 648.50
Y-mAbs Therapeutics (YMAB) United States $1.539B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.490B 0.00
REGENXBIO (RGNX) United States $1.489B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.485B 0.00
Sangamo Therapeutics (SGMO) United States $1.430B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.430B 0.00
BioAtla (BCAB) United States $1.389B 0.00
Ocugen (OCGN) United States $1.376B 0.00
PureTech Health (PRTC) United States $1.375B 0.00
Nurix Therapeutics (NRIX) United States $1.365B 0.00
Codexis (CDXS) United States $1.351B 0.00
MiMedx (MDXG) United States $1.323B 0.00
Zealand Pharma (ZEAL) Denmark $1.274B 0.00
Agenus (AGEN) United States $1.250B 0.00
Repare Therapeutics (RPTX) Canada $1.237B 0.00
UniQure (QURE) Netherlands $1.197B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.162B 0.00
Scholar Rock Holding (SRRK) United States $1.124B 0.00
Precigen (PGEN) United States $1.117B 0.00
Northwest Biotherapeutics (NWBO) United States $1.097B 0.00
Inhibrx (INBX) United States $1.097B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.091B 34.46
MannKind (MNKD) United States $1.089B 0.00
Dynavax Technologies (DVAX) United States $1.085B 0.00
Nkarta (NKTX) United States $1.055B 0.00
Zealand Pharma (ZLDPF) Denmark $1.035B 0.00
Coherus BioSciences (CHRS) United States $0.990B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.964B 0.00
Mesoblast (MESO) Australia $0.942B 0.00
Shattuck Labs (STTK) United States $0.935B 0.00
Pliant Therapeutics (PLRX) United States $0.912B 0.00
Keros Therapeutics (KROS) United States $0.879B 0.00
Adagene (ADAG) China $0.873B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.850B 0.00
Prometheus Biosciences (RXDX) United States $0.838B 0.00
Mersana Therapeutics (MRSN) United States $0.828B 0.00
Avidity Biosciences (RNA) United States $0.827B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.822B 0.00
RAPT THERAPTICS (RAPT) United States $0.805B 0.00
Travere Therapeutics (TVTX) United States $0.800B 0.00
Sutro Biopharma (STRO) United States $0.787B 0.00
VBI Vaccines (VBIV) United States $0.758B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.750B 0.00
G1 THERAPEUTICS (GTHX) United States $0.743B 0.00
Pharming Group (PHAR) Netherlands $0.732B 0.00
Kadmon Holdings (KDMN) United States $0.724B 0.00
IDEAYA Biosciences (IDYA) United States $0.722B 0.00
Epizyme (EPZM) United States $0.710B 0.00
AnaptysBio (ANAB) United States $0.705B 0.00
Merus (MRUS) Netherlands $0.703B 0.00
Pharming Group (PHGUF) Netherlands $0.701B 22.40
Syndax Pharmaceuticals (SNDX) United States $0.688B 0.00
Curis (CRIS) United States $0.684B 0.00
Affimed (AFMD) Germany $0.678B 0.00
Seres Therapeutics (MCRB) United States $0.678B 0.00
SESEN BIO, INC (SESN) United States $0.669B 0.00
MeiraGTx Holdings (MGTX) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
ChromaDex (CDXC) United States $0.640B 0.00
Cellectis S.A (CLLS) France $0.625B 0.00
Akoya Biosciences (AKYA) United States $0.608B 0.00
Cara Therapeutics (CARA) United States $0.598B 51.91
ALBIREO PHARMA (ALBO) United States $0.591B 0.00
DBV Technologies S.A (DBVT) France $0.590B 0.00
Precision BioSciences (DTIL) United States $0.589B 0.00
Anika Therapeutics (ANIK) United States $0.580B 0.00
Verastem (VSTM) United States $0.569B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.563B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.560B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.558B 0.00
VistaGen Therapeutics (VTGN) United States $0.549B 0.00
AC Immune SA (ACIU) Switzerland $0.542B 0.00
Inventiva S.A (IVA) France $0.535B 0.00
Clovis Oncology (CLVS) United States $0.508B 0.00
Vaccitech (VACC) United Kingdom $0.504B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.491B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.483B 0.00
Clene (CLNN) United States $0.482B 0.00
XBiotech (XBIT) United States $0.479B 0.00
Compugen (CGEN) Israel $0.456B 0.00
Bolt Biotherapeutics (BOLT) United States $0.449B 0.00
Cybin (CLXPF) Canada $0.446B 0.00
Spero Therapeutics (SPRO) United States $0.426B 0.00
Oncobiologics (OTLK) United States $0.420B 0.00
Kindred Biosciences (KIN) United States $0.415B 0.00
Geron (GERN) United States $0.411B 0.00
ANI Pharmaceuticals (ANIP) United States $0.410B 11.31
Forte Biosciences (FBRX) United States $0.410B 0.00
Amryt Pharma (AMYT) United Kingdom $0.401B 0.00
Selecta Biosciences (SELB) United States $0.392B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.389B 0.00
SQZ Biotechnologies (SQZ) United States $0.388B 0.00
Starpharma Holdings (SPHRY) Australia $0.384B 0.00
BeyondSpring (BYSI) United States $0.381B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.379B 0.00
XOMA (XOMA) United States $0.376B 175.79
Gritstone Bio (GRTS) United States $0.373B 0.00
Codiak BioSciences (CDAK) United States $0.368B 0.00
CytomX Therapeutics (CTMX) United States $0.361B 0.00
BioDelivery Sciences (BDSI) United States $0.360B 14.60
Athenex (ATNX) United States $0.351B 0.00
AquaBounty Technologies (AQB) United States $0.347B 0.00
Athersys (ATHX) United States $0.339B 0.00
Neoleukin Therapeutics (NLTX) United States $0.339B 0.00
Opthea (OPT) Australia $0.339B 0.00
INmune Bio (INMB) United States $0.334B 0.00
Theratechnologies (THTX) Canada $0.332B 0.00
Cue Biopharma (CUE) United States $0.330B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.322B 0.00
UROGEN PHARMA (URGN) United States $0.320B 0.00
Angion Biomedica (ANGN) United States $0.319B 0.00
Puma Biotechnology (PBYI) United States $0.313B 0.00
Talis Biomedical (TLIS) United States $0.300B 0.00
Fortress Biotech (FBIO) United States $0.298B 0.00
Clearside Biomedical (CLSD) United States $0.295B 0.00
WAVE Life Sciences (WVE) Singapore $0.294B 0.00
Syros Pharmaceuticals (SYRS) United States $0.290B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.276B 0.00
Cerecor (CERC) United States $0.272B 0.00
Arbutus Biopharma (ABUS) United States $0.266B 0.00
Prima BioMed (IMMP) Australia $0.264B 0.00
Fulcrum Therapeutics (FULC) United States $0.261B 0.00
Innate Pharma S.A (IPHA) France $0.261B 0.00
Adicet Bio (ACET) United States $0.259B 0.00
Frequency Therapeutics (FREQ) United States $0.258B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.257B 0.00
OVID THERAPEUTC (OVID) United States $0.254B 2.49
Cogent Biosciences (COGT) United States $0.249B 0.00
Kamada (KMDA) Israel $0.248B 16.85
Chiasma (CHMA) United States $0.245B 0.00
Trevena (TRVN) United States $0.242B 0.00
Kaleido Biosciences (KLDO) $0.241B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.237B 0.00
CorMedix Inc (CRMD) United States $0.234B 0.00
Kala Pharmaceuticals (KALA) United States $0.233B 0.00
Adverum Biotechnologies (ADVM) United States $0.231B 0.00
OSMOTICA PHARM (OSMT) United States $0.231B 0.00
TELA Bio (TELA) United States $0.220B 0.00
Bellus Health (BLU) Canada $0.219B 0.00
Checkpoint Therapeutics (CKPT) United States $0.217B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.206B 0.00
Cardiff Oncology (CRDF) United States $0.199B 0.00
NextCure (NXTC) United States $0.195B 0.00
HOOKIPA Pharma (HOOK) United States $0.193B 0.00
Biofrontera AG (BFRA) Germany $0.188B 0.00
Seelos Therapeutics (SEEL) United States $0.183B 0.00
Aptinyx (APTX) United States $0.181B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.178B 0.00
Strongbridge Biopharma (SBBP) United States $0.176B 0.00
Beyond Air (XAIR) United States $0.175B 0.00
GENFIT S.A (GNFT) France $0.174B 0.00
Nicox SA (NICXF) France $0.171B 0.00
POXEL SA FRANCE (PXXLF) France $0.170B 0.00
PHASEBIO PHARMA (PHAS) United States $0.168B 0.00
Cyclerion Therapeutics (CYCN) United States $0.167B 0.00
Synlogic (SYBX) United States $0.167B 0.00
VTv Therapeutics (VTVT) United States $0.164B 0.00
Applied Genetic Technologies (AGTC) United States $0.160B 0.00
Enzo Biochem (ENZ) United States $0.152B 44.71
Antibe Therapeutics (ATBPF) Canada $0.146B 0.00
Viridian Therapeutics (VRDN) United States $0.145B 0.00
X4 Pharmaceuticals (XFOR) United States $0.142B 0.00
ObsEva SA (OBSV) Switzerland $0.142B 0.00
Eton Pharmaceuticals (ETON) United States $0.137B 0.00
Catalyst Biosciences (CBIO) United States $0.135B 0.00
LogicBio Therapeutics (LOGC) United States $0.133B 0.00
Galena Biopharma (SLS) United States $0.132B 0.00
ABVC BioPharma (ABVC) United States $0.132B 0.00
Abeona Therapeutics (ABEO) United States $0.130B 0.00
Purple Biotech (PPBT) Israel $0.128B 0.00
Liquidia Technologies (LQDA) United States $0.128B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.127B 0.00
Novogen (KZIA) Australia $0.126B 0.00
Entera Bio (ENTX) Israel $0.126B 0.00
Exicure (XCUR) United States $0.126B 0.00
Erytech Pharma SA (ERYP) France $0.125B 0.00
Orgenesis (ORGS) United States $0.125B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.120B 0.00
Eyenovia (EYEN) United States $0.119B 0.00
Voyager Therapeutics (VYGR) United States $0.118B 3.03
Longeveron (LGVN) United States $0.118B 0.00
Cocrystal Pharma (COCP) United States $0.111B 0.00
Vascular Biogenics (VBLT) Israel $0.109B 0.00
Pluristem Therapeutics (PSTI) Israel $0.109B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.106B 0.00
Aytu BioPharma (AYTU) United States $0.103B 0.00
Dyadic (DYAI) United States $0.098B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.098B 0.00
Liminal BioSciences (LMNL) Canada $0.098B 0.00
Yumanity Therapeutics (YMTX) United States $0.092B 0.00
Aptevo Therapeutics (APVO) United States $0.092B 0.00
Evofem Biosciences (EVFM) United States $0.092B 0.00
Celsion (CLSN) United States $0.091B 0.00
Vyant Bio (VYNT) United States $0.089B 0.00
ARAVIVE, INC (ARAV) United States $0.087B 0.00
AEterna Zentaris (AEZS) United States $0.086B 0.00
Zosano Pharma (ZSAN) United States $0.086B 0.00
Leap Therapeutics (LPTX) United States $0.082B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.082B 0.00
AIkido Pharma (AIKI) United States $0.079B 0.00
Adocia (ADOCY) France $0.077B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
Cidara Therapeutics (CDTX) United States $0.074B 0.00
Celyad SA (CYAD) Belgium $0.072B 0.00
ATyr Pharma (LIFE) United States $0.072B 0.00
Cleveland BioLabs (CBLI) United States $0.071B 0.00
DiaMedica Therapeutics (DMAC) United States $0.069B 0.00
Edesa Biotech (EDSA) Canada $0.069B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Lumos Pharma (LUMO) United States $0.064B 0.00
BioCardia (BCDA) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Advaxis (ADXS) United States $0.061B 0.00
Oncotelic Therapeutics (OTLC) United States $0.061B 0.00
TRACON Pharmaceuticals (TCON) United States $0.059B 0.00
ARIDIS PHARMACT (ARDS) United States $0.058B 0.00
Cyclo Therapeutics (CYTH) United States $0.057B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Genetic Technologies (GENE) Australia $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.053B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.051B 0.00
Pulmatrix (PULM) United States $0.050B 0.00
Windtree Therapeutics (WINT) United States $0.048B 0.00
AnPac Bio-Medical Science (ANPC) China $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.046B 0.00
Invo BioScience (INVO) United States $0.045B 0.00
Acorda Therapeutics (ACOR) United States $0.045B 1.08
Enveric Biosciences (ENVB) United States $0.041B 0.00
Soligenix (SNGX) United States $0.039B 0.00
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
Vallon Pharmaceuticals (VLON) United States $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
ThermoGenesis Holdings (THMO) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
ZIVO Bioscience (ZIVO) United States $0.020B 0.00
Palisade Bio (PALI) United States $0.010B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00